World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
96
Citations
30762
World Ranking
865
National Ranking
26

Medicine

D-Index
96
Citations
31021
World Ranking
9746
National Ranking
343

Giovanni Monteleone publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Giovanni Monteleone sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 576 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Giovanni Monteleone D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Giovanni Monteleone sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 96 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Giovanni Monteleone is affiliated with the University of Rome Tor Vergata in Italy. Their research spans a wide range of topics within medicine and the biological sciences, with a particular focus on inflammatory bowel disease and related gastrointestinal conditions.

The scientist's work has extensively covered several main fields of study, including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of particular interest include:

  • Surgery
  • Genetics
  • Oncology
  • Epidemiology
  • Immunology

Key topics addressed in their research are:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Gastric Cancer Management and Outcomes
  • Gallbladder and Bile Duct Disorders
  • Diverticular Disease and Complications
  • COVID-19 Clinical Research Studies
  • Pancreatic and Hepatic Oncology Research

Giovanni Monteleone has multiple frequent co-authors with whom collaborations have been sustained through numerous publications. These include:

  • Irene Marafini
  • Edoardo Troncone
  • Emma Calabrese
  • Federica Laudisi
  • Livia Biancone

The scientist has published work in a variety of scientific journals, with frequent contributions to:

  • Digestive and Liver Disease
  • Cancers
  • Endoscopy
  • Journal of Crohn's and Colitis
  • Gastroenterology

Selected recent papers authored or co-authored by Giovanni Monteleone include:

  • Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?, 2020, Journal of Crohn's and Colitis
  • Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases, 2022, Biomedicines
  • Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial, 2022, The Lancet
  • Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms, 2023, International Journal of Molecular Sciences
  • The impact of COVID-19 pandemic in the colorectal cancer prevention, 2020, International Journal of Colorectal Disease

Best Publications

  • Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.

    Massimo C. Fantini;Christoph Becker;Giovanni Monteleone;Francesco Pallone

  • Immunity, Inflammation, and Allergy in the Gut

    Thomas T. MacDonald;Giovanni Monteleone

  • Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease

    Giovanni Monteleone;Andrea Kumberova;Nicholas M. Croft;Catriona McKenzie

  • Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells

    G Monteleone;L Biancone;R Marasco;G Morrone

  • Aryl Hydrocarbon Receptor-Induced Signals Up-regulate IL-22 Production and Inhibit Inflammation in the Gastrointestinal Tract

    Ivan Monteleone;Angelamaria Rizzo;Massimiliano Sarra;Giuseppe Sica

  • Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.

    V De Simone;E Franzè;G Ronchetti;A Colantoni

  • Bioactive IL-18 expression is up-regulated in Crohn's disease.

    Giovanni Monteleone;Francesco Trapasso;Tiziana Parrello;Livia Biancone

  • Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease

    Giovanni Monteleone;Markus F. Neurath;Sandro Ardizzone;Antonio Di Sabatino

  • The gut-skin axis in health and disease: A paradigm with therapeutic implications

    Catherine A. O'Neill;Giovanni Monteleone;John T. McLaughlin;Ralf Paus;Ralf Paus

  • S1731 Differential Regulation of Interleukin-17 and Interferon-γ Production in Inflammatory Bowel Disease

    L. Rovedatti;T. Kudo;P. Biancheri;M. Sarra

  • Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn’s disease

    Giovanni Monteleone;Ivan Monteleone;Daniele Fina;Piero Vavassori

  • IL-21 Counteracts the Regulatory T Cell-Mediated Suppression of Human CD4+ T Lymphocytes

    Ilaria Peluso;Massimo Claudio Fantini;Daniele Fina;Roberta Caruso

  • Recent developments in the immunology of inflammatory bowel disease.

    T T MacDonald;G Monteleone;S L Pender

  • UP-REGULATION OF IL-17 IS ASSOCIATED WITH BIOACTIVE IL-8 EXPRESSION IN HELICOBACTER PYLORI-INFECTED HUMAN GASTRIC MUCOSA

    Francesco Luzza;Tiziana Parrello;Giovanni Monteleone;Ladislava Sebkova

  • Regulation of Gut Inflammation and Th17 Cell Response by Interleukin-21

    Daniele Fina;Massimiliano Sarra;Massimo C. Fantini;Angelamaria Rizzo

  • IL‐23/IL‐17 axis in IBD

    Massimiliano Sarra;Francesco Pallone;Thomas T. MacDonald;Giovanni Monteleone

  • Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

    Unknown

  • Regulation of homeostasis and inflammation in the intestine.

    Thomas T. MacDonald;Ivan Monteleone;Massimo Claudio Fantini;Giovanni Monteleone

  • Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25− T Cells

    Sabine Dominitzki;Massimo C. Fantini;Clemens Neufert;Alexei Nikolaev

  • Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis.

    Vincenzo Dinallo;Irene Marafini;Davide Di Fusco;Federica Laudisi

  • Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis.

    Roberta Caruso;Elisabetta Botti;Massimiliano Sarra;Maria Esposito

  • Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21

    Giovanni Monteleone;Roberta Caruso;Daniele Fina;Ilaria Peluso

Frequent Co-Authors

Francesco Pallone
Francesco Pallone University of Rome Tor Vergata
Thomas T. MacDonald
Thomas T. MacDonald University of Southampton
Massimo Fantini
Massimo Fantini Precision Biologics
Gino Roberto Corazza
Gino Roberto Corazza University of Pavia
Markus F. Neurath
Markus F. Neurath University of Erlangen-Nuremberg
Enrico Solcia
Enrico Solcia University of Pavia
Massimo Rugge
Massimo Rugge University of Padua
Massimo Federici
Massimo Federici University of Rome Tor Vergata
Catherine Klersy
Catherine Klersy University of Pavia
Marco Paulli
Marco Paulli University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often involves complementary educational paths that enhance clinical understanding and practical skills. Many students consider bridging programs such as the fnp to acnp bridge program online, which prepares family nurse practitioners for acute care roles. This pathway is valuable for those interested in specialized patient care related to immunological conditions.

For those seeking a faster entry into advanced nursing roles, accelerated np programs online offer condensed curriculums that can be completed more quickly than traditional degrees. This allows professionals to advance their careers efficiently while maintaining a focus on relevant immunological competencies.

Individuals without a nursing background interested in immunology might explore foundational options such as online bsn programs for non nurses. These programs provide the essential clinical training needed before pursuing specialized graduate studies or certifications in immunology-related fields.

Additionally, choosing the easiest absn to get into can be a strategic step for students aiming to enter the nursing profession swiftly. This can lead to quicker eligibility for immunology-focused advanced practice roles, making it a practical choice for career advancement.

Best Scientists Citing Giovanni Monteleone

Trending Scientists

Recently Published Articles